438 related articles for article (PubMed ID: 27475987)
1. Antibiotic resistance is the quintessential One Health issue.
Robinson TP; Bu DP; Carrique-Mas J; Fèvre EM; Gilbert M; Grace D; Hay SI; Jiwakanon J; Kakkar M; Kariuki S; Laxminarayan R; Lubroth J; Magnusson U; Thi Ngoc P; Van Boeckel TP; Woolhouse ME
Trans R Soc Trop Med Hyg; 2016 Jul; 110(7):377-80. PubMed ID: 27475987
[No Abstract] [Full Text] [Related]
2. [Clinical implications of antibiotic resistance of enterococci].
Besnier JM; Leport C
Presse Med; 1997 Nov; 26(37):1781-7. PubMed ID: 9569899
[No Abstract] [Full Text] [Related]
3. Thinking Outside the Bug: Molecular Targets and Strategies to Overcome Antibiotic Resistance.
Monserrat-Martinez A; Gambin Y; Sierecki E
Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30871132
[TBL] [Abstract][Full Text] [Related]
4. Management of antibiotic resistance in the intensive care unit setting.
Petrosillo N; Capone A; Di Bella S; Taglietti F
Expert Rev Anti Infect Ther; 2010 Mar; 8(3):289-302. PubMed ID: 20192683
[TBL] [Abstract][Full Text] [Related]
5. Antibiotics for gram-positive bacterial infections. Vancomycin, teicoplanin, quinupristin/dalfopristin, and linezolid.
Lundstrom TS; Sobel JD
Infect Dis Clin North Am; 2000 Jun; 14(2):463-74. PubMed ID: 10829266
[TBL] [Abstract][Full Text] [Related]
6. Antibiotic resistance to Propionobacterium acnes: worldwide scenario, diagnosis and management.
Sardana K; Gupta T; Garg VK; Ghunawat S
Expert Rev Anti Infect Ther; 2015 Jul; 13(7):883-96. PubMed ID: 26025191
[TBL] [Abstract][Full Text] [Related]
7. [Enterococcal resistance to glycopeptide antibiotics].
Cercendado Mansilla E
Rev Clin Esp; 1995 Oct; 195 Suppl 4():22-7. PubMed ID: 9441312
[No Abstract] [Full Text] [Related]
8. Daptomycin: a new treatment for insidious infections due to gram-positive pathogens.
Cottagnoud P
Swiss Med Wkly; 2008 Feb; 138(7-8):93-9. PubMed ID: 18293118
[TBL] [Abstract][Full Text] [Related]
9. Which antibiotic for resistant Gram-positives, and why?
Bradley JS
J Infect; 2014 Jan; 68 Suppl 1():S63-75. PubMed ID: 24188585
[TBL] [Abstract][Full Text] [Related]
10. Preface.
French G
Int J Antimicrob Agents; 2000 Nov; 16 Suppl 1():S1. PubMed ID: 11137401
[No Abstract] [Full Text] [Related]
11. [Enterococcal resistance to beta-lactam and aminoglycoside antibiotics].
Liñares Louzao J; Ayats Ardite J; Alonso Figueres T
Rev Clin Esp; 1995 Oct; 195 Suppl 4():16-21. PubMed ID: 9441311
[No Abstract] [Full Text] [Related]
12. Glycopeptide-resistant Gemella haemolysans from blood.
Reed C; Efstratiou A; Morrison D; Woodford N
Lancet; 1993 Oct; 342(8876):927-8. PubMed ID: 8105186
[No Abstract] [Full Text] [Related]
13. Mitigating Antibiotic Resistance at the Livestock-Environment Interface:A Review.
Ma Z; Lee S; Jeong KC
J Microbiol Biotechnol; 2019 Nov; 29(11):1683-1692. PubMed ID: 31693837
[TBL] [Abstract][Full Text] [Related]
14. Use of bacitracin therapy for infection due to vancomycin-resistant Enterococcus faecium.
Chia JK; Nakata MM; Park SS; Lewis RP; McKee B
Clin Infect Dis; 1995 Dec; 21(6):1520. PubMed ID: 8749657
[No Abstract] [Full Text] [Related]
15. N-Terminal guanidine derivatives of teicoplanin antibiotics strongly active against glycopeptide resistant Enterococcus faecium.
Szűcs Z; Bereczki I; Rőth E; Milánkovits M; Ostorházi E; Batta G; Nagy L; Dombrádi Z; Borbás A; Herczegh P
J Antibiot (Tokyo); 2020 Sep; 73(9):603-614. PubMed ID: 32409678
[TBL] [Abstract][Full Text] [Related]
16. Antibiotics in acne: time for a rethink.
Simpson N
Br J Dermatol; 2001 Feb; 144(2):225-7. PubMed ID: 11251550
[No Abstract] [Full Text] [Related]
17. Clinical implications of nosocomial gram-positive bacteremia and superimposed antimicrobial resistance.
Linden PK
Am J Med; 1998 May; 104(5A):24S-33S. PubMed ID: 9684655
[TBL] [Abstract][Full Text] [Related]
18. Trends in treatment of antimicrobial-resistant enterococcal infections.
Xia L; Murray BE
Curr Clin Top Infect Dis; 2000; 20():92-112. PubMed ID: 10943520
[No Abstract] [Full Text] [Related]
19. Comparison of the CLSI guideline and ISO/IDF standard for antimicrobial susceptibility testing of Lactobacilli.
Mayrhofer S; Zitz U; Birru FH; Gollan D; Gołoś AK; Kneifel W; Domig KJ
Microb Drug Resist; 2014 Dec; 20(6):591-603. PubMed ID: 24901389
[TBL] [Abstract][Full Text] [Related]
20. [Vancomycin-resistant enterococci . Work Group Hospital Infection Epidemiology].
Endtz HP; van Belkum A; van Duin J
Ned Tijdschr Geneeskd; 1997 Jan; 141(2):108-9. PubMed ID: 9036340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
